Yamashita K - Search Results

1

Re: Is TIG1 a new tumor suppressor in prostate cancer?

Tokumaru Y, Sun DI, Nomoto S, Yamashita K, Sidransky D. Tokumaru Y, et al. Among authors: yamashita k. J Natl Cancer Inst. 2003 Jun 18;95(12):919-20. doi: 10.1093/jnci/95.12.919. J Natl Cancer Inst. 2003. PMID: 12813179 No abstract available.

2

Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing.

Tokumaru Y, Yamashita K, Osada M, Nomoto S, Sun DI, Xiao Y, Hoque MO, Westra WH, Califano JA, Sidransky D. Tokumaru Y, et al. Among authors: yamashita k. Cancer Res. 2004 Sep 1;64(17):5982-7. doi: 10.1158/0008-5472.CAN-04-0993. Cancer Res. 2004. PMID: 15342377

3

The role of PGP9.5 as a tumor suppressor gene in human cancer.

Tokumaru Y, Yamashita K, Kim MS, Park HL, Osada M, Mori M, Sidransky D. Tokumaru Y, et al. Among authors: yamashita k. Int J Cancer. 2008 Aug 15;123(4):753-9. doi: 10.1002/ijc.23354. Int J Cancer. 2008. PMID: 18512240 Free PMC article.

4

Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma.

Yamashita K, Upadhyay S, Osada M, Hoque MO, Xiao Y, Mori M, Sato F, Meltzer SJ, Sidransky D. Yamashita K, et al. Cancer Cell. 2002 Dec;2(6):485-95. doi: 10.1016/s1535-6108(02)00215-5. Cancer Cell. 2002. PMID: 12498717 Free article.

5

A tumor-suppressive role for trypsin in human cancer progression.

Yamashita K, Mimori K, Inoue H, Mori M, Sidransky D. Yamashita K, et al. Cancer Res. 2003 Oct 15;63(20):6575-8. Cancer Res. 2003. PMID: 14583448

6

Optimal use of a panel of methylation markers with GSTP1 hypermethylation in the diagnosis of prostate adenocarcinoma.

Tokumaru Y, Harden SV, Sun DI, Yamashita K, Epstein JI, Sidransky D. Tokumaru Y, et al. Among authors: yamashita k. Clin Cancer Res. 2004 Aug 15;10(16):5518-22. doi: 10.1158/1078-0432.CCR-04-0108. Clin Cancer Res. 2004. PMID: 15328191

7

PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma.

Mandelker DL, Yamashita K, Tokumaru Y, Mimori K, Howard DL, Tanaka Y, Carvalho AL, Jiang WW, Park HL, Kim MS, Osada M, Mori M, Sidransky D. Mandelker DL, et al. Among authors: yamashita k. Cancer Res. 2005 Jun 1;65(11):4963-8. doi: 10.1158/0008-5472.CAN-04-3923. Cancer Res. 2005. PMID: 15930319

8

N-methyl-D-aspartate receptor type 2B is epigenetically inactivated and exhibits tumor-suppressive activity in human esophageal cancer.

Kim MS, Yamashita K, Baek JH, Park HL, Carvalho AL, Osada M, Hoque MO, Upadhyay S, Mori M, Moon C, Sidransky D. Kim MS, et al. Among authors: yamashita k. Cancer Res. 2006 Apr 1;66(7):3409-18. doi: 10.1158/0008-5472.CAN-05-1608. Cancer Res. 2006. PMID: 16585162

9

PGP9.5 methylation in diffuse-type gastric cancer.

Yamashita K, Park HL, Kim MS, Osada M, Tokumaru Y, Inoue H, Mori M, Sidransky D. Yamashita K, et al. Cancer Res. 2006 Apr 1;66(7):3921-7. doi: 10.1158/0008-5472.CAN-05-1511. Cancer Res. 2006. PMID: 16585221

10

HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.

Yamashita K, Kim MS, Park HL, Tokumaru Y, Osada M, Inoue H, Mori M, Sidransky D. Yamashita K, et al. Mol Cancer Res. 2008 Jan;6(1):31-41. doi: 10.1158/1541-7786.MCR-07-0213. Mol Cancer Res. 2008. PMID: 18234960

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,602 results

Search Page

Filters